Chronic kidney disease dialysis service provider DaVita (NYSE:DVA) and its 118,000 patients receiving kidney care know how serious this disease is. The Denver-based company understands that its success or failure treating patients lies in the hands and minds of dedicated employees. Long ago, it realized a democratic workplace was the best environment for employees to perform their jobs in an exceptional manner. This decision has paid financial dividends as well as human resource accolades. Recently, it was named by WorldBlu - an Austin-based nonprofit dedicated to organizational democracy - as one of the 44 most democratic workplaces worldwide.

IN PICTURES: 5 Investing Statements That Make You Sound Stupid

They're Hiring
Any company hiring today is likely in good financial health. DaVita's career site lists 1,222 full and part-time positions available. That's 3.6% of its overall workforce of 34,000. Naturally, some of these openings are due to staff turnover, but the rest are new jobs due to an increasing number of patients. Management's outlook for 2010 calls for operating income between $950 million and $1.02 billion. With an operating margin of 15.4%, it should generate revenues of $6.4 billion in 2010 from approximately 123,800 patients, an increase of 4.9% year-over-year. It's not massive growth, but it's enough, given its ability to generate cash.

Lots of Cash
DaVita finished 2009 with free cash flow of $485 million or 8% of revenues. It currently has $5.43 a share in cash with its stock trading at 12.1-times cash. The table below lists some of its specialized health services peer group. With the exception of MDS, DaVita's stock is trading at the most reasonable valuation among them. But most of its cash comes from the sale of its Analytical Technologies and Pharma Services divisions for $650 million and $45 million respectively. It will now focus on its Nordion division, which specializes in medical imaging, with revenues about one-fifth its former size. Therefore, at least in terms of cash, DaVita easily is the winner. (Cash in the bank is what every company strives to achieve. Find out how to determine how much a company is generating and keeping, in Free Cash Flow Yield: The Best Fundamental Indicator.)

DaVita and Peer Group
Company Market Cap Price/Cash
DaVita (NYSE:DVA) $6.8 billion 12.1
Mednax (NYSE:MD) $2.7 billion 85.4
Healthsouth (NYSE:HLS) $1.9 billion 22.4
Psychiatric Solutions (Nasdaq:PSYS) $1.8 billion 264.8
MDS (NYSE:MDZ) $1.1 billion 1.22

Steady Stock
In the past five years, DaVita stock averaged annual returns of 9.8%, 860 basis points better than the S&P 500. Over a 10-year period, it beat the index by an impressive 42.4% annually. Year-to-date it's up 11.7%, again outpacing the S&P 500. Only in 2007 did it underperform the index. How did it do it? CEO Kent Thiry transformed the company into a democratic, caring workplace. It might not seem like much but when he took over the company in 1999, it was ready for the healthcare scrap heap. Now it's the only healthcare company on the WorldBlu list for the third consecutive year. A lot's changed since then. Revenues have grown from $1 billion to over $6 billion, the number of dialysis locations from 450 to 1,800 and its market cap from $150 million to $6 billion. By keeping employees engaged the company has been able to grab 30% market share with more to come.

Odds and Ends
In addition to WorldBlu, it's been given several other accolades from Training Magazine, Fortune and Modern Healthcare. According to Fast Company, employees have a vote on most issues and each clinic establishes its own guidelines rather than receiving direction from the head office. It sounds empowering. Ironically, one of the other companies on WorldBlu's list, Glassdoor.com, has a number of unflattering reviews from current and former employees. It's certainly something to keep an eye on. Sometimes a reputation gained is tough to lose. (Find out why some companies thrive while others flounder, see Economic Moats: A Successful Company's Best Defense.)

The Bottom Line
There's a lot to like about DaVita. Having said that, healthcare is an extremely volatile sector of the economy. You need to be prepared for the inevitable changes coming because of healthcare reform. In terms of its current valuation, I see it trading at or slightly below its historical norms. If you're a long-term investor, there should be no problem here. Buy away.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Fundamental Analysis

    The 3 Best Investments When Bull Markets Slow Down

    Find out why no bull market lasts forever, and why investors should shift their assets away from growth and toward dividends when stocks slow down.
  2. Charts & Patterns

    How To Use Volume To Improve Your Trading

    The basic guidelines to analyzing volume may not apply in all situations, but overall, they can help direct entry and exit decisions.
  3. Economics

    Understanding Cost-Volume Profit Analysis

    Business managers use cost-volume profit analysis to gauge the profitability of their company’s products or services.
  4. Fundamental Analysis

    5 Must-Have Metrics For Value Investors

    Focusing on certain fundamental metrics is the best way for value investors to cash in gains. Here are the most important metrics to know.
  5. Trading Strategies

    4 Common Active Trading Strategies

    Active trading entails buying and selling securities with the intent of profiting from short-term price movements.
  6. Investing News

    Market Outlook: No Bottom Until 2017?

    These investing pros are bearish on the market in 2016. Will there be a bottom in early 2017?
  7. Investing

    How To Make Sure Your Healthcare Costs Do Not Ruin Your Retirement

    The best proactive plan of action for a stable retirement is to understand medical costs, plan ahead, invest properly, and consider supplemental insurance.
  8. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  9. Investing News

    Building a Case for the Bulls: 3 Opinions

    These three big names are bullish on the economy. Are there good times ahead?
  10. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
RELATED FAQS
  1. What is Fibonacci retracement, and where do the ratios that are used come from?

    Fibonacci retracement is a very popular tool among technical traders and is based on the key numbers identified by mathematician ... Read Full Answer >>
  2. Does dental insurance cover implants?

    Dental implants have become a widely used procedure in dentistry. Despite their popularity, however, they tend to not be ... Read Full Answer >>
  3. Does dental insurance cover dentures?

    Most full dental insurance policies include some restorative coverage, usually meaning that up to 50% of the cost of dentures ... Read Full Answer >>
  4. Can CareCredit be used for family members?

    CareCredit has become a widely used option when it comes to paying for medical procedures, primarily procedures not typically ... Read Full Answer >>
  5. Can a Flexible Spending Account (FSA) be used for dental?

    Flexible Spending Accounts (FSAs) can be used to pay for dental expenses including deductibles and co-payments with pretax ... Read Full Answer >>
  6. Does dental insurance cover braces?

    Most regular dental plans cover little to none of the costs of braces. The primary focus of regular dental plans is prevention ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center